🇺🇸 FDA
Patent

US 8486898

Compounds and method for inhibiting the activity of gelatinase and collagenase

granted A61KA61K2800/782A61K8/60

Quick answer

US patent 8486898 (Compounds and method for inhibiting the activity of gelatinase and collagenase) held by China Medical University expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2800/782, A61K8/60